Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-642-3 | CAS number: 106-78-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-08-22 to 2000-09-15
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1992
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 1998
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 1996
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Test was conducted in 2000
Test material
- Reference substance name:
- 2-{2-[(2-chloroacetyl)oxy]ethoxy}ethyl 2-chloroacetate
- Cas Number:
- 106-78-5
- Molecular formula:
- C8H12O5Cl2
- IUPAC Name:
- 2-{2-[(2-chloroacetyl)oxy]ethoxy}ethyl 2-chloroacetate
- Test material form:
- liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Hsd Poc:DH
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH Laboratory Animal Breeders in 33176 Borchen
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF-bred
- Age at study initiation: 3 - 6 weeks
- Weight at study initiation: 295 - 360 grams
- Housing: IV Makrolon® cages, in groups of five during the adaptation period and in groups of two or three per cage throughout the study period. Low-dust wood shavings were used as bedding.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least seven days
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/-3°C (possibly drifting higher at outdoor temperatures above 24°C)
- Humidity (%): 40 - 60 %
- Air changes (per hr): >= 10 times per hour
- Photoperiod (hrs dark / hrs light): Twelve hours; artificial lighting from 6 AM to 6 PM
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- polyethylene glycol
- Remarks:
- 400
- Concentration / amount:
- Intradermal induction: 5% (= 20 mg test item/animal)
Topical induction: 12% (= 60 mg test item/animal) - Day(s)/duration:
- Day 0 Intradermal; one week after intradermal induction topical application for 48 h
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- Route:
- other: epicutaneous, using hypoallergenic patch loaded with the test item formulation and held securely in place on the skin with a ORABAND® selfadhesive tape
- Vehicle:
- polyethylene glycol
- Remarks:
- 400
- Concentration / amount:
- 6% (= 30 mg test item/animal)
- Day(s)/duration:
- Three weeks after intradermal induction
- Adequacy of challenge:
- other: non-irritant concentration
- No. of animals per dose:
- 10 per dose and 5 in the control group
- Details on study design:
- RANGE FINDING TESTS: Based on the results of the preliminary test the concentrations for the main study was determined
Individual Range-finding (Pilot) Test Results:
- Dose-range finding study for intradermal induction: One guinea pig was given intradermal injections twice, in each case, with 0.1 ml of the following test item concentrations: 0%, 1%, 2.5% and 5%. The injection sites were evaluated after 24 and 48 hours
- Dose range-finding study for topical induction:
Three different concentrations and the vehicle were tested in each case on four guinea pigs. The patches moistened with 0.5 ml of the test item formulations or the vehicle were applied to each animal under occlusive conditions for 24 hours. At the end ofthe exposure period, the remaining test item or the vehicle were removed with physiological saline solution and twenty-one hours later the treated areas were shorn. The skin reactions were evaluated 48 hours and 72 hours after the start of the application
- Dose range-finding study for challenge:
One week prior to the challenge, the challenge concentration was determined on 2 guinea pigs in the main study that were treated in the same manner as the control animals during the inductions.
Four patches each loaded with 0.5 ml test item formulation or the vehicle were applied to each animal under occlusive conditions for 24 hours. At the end of the exposure period, the remaining test item was removed with physiological saline solution and twenty-one hours later the treated areas were shorn. The skin reactions were evaluated 48 hours and 72 hours after the start ofthe application.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (first induction: intradermal exposure; second induction: epicutaneous exposure)
- Exposure period: three weeks
- Test groups: 1 (intradermal induction)
1. Injection site: cranial/bilateral complete Freund's adjuvant (DIFCO LAB.) diluted 1:1 with sterile physiological saline solution
2. Injection site: medial/bilateral 5% WARO 318 formulated in polyethylene glycol 400
3. Injection site: caudal/bilateral 5% WARO 318 formulated at equal parts in sterile physiological saline solution and complete Freund's adjuvant.
- Control group: 1
The animals ofthe control group were treated in the same manner as the animals of the test item group; however, the formulations for injection site pairs 2 and 3 did not contain any test item but in pair 2 undiluted vehicle and in pair 3 a 50% formulation of the vehicle in a 1:1 mixture FCN/physiological saline solution.
- Site: Starting behind the nape of the neck, three injections each in a row were made on the left and the right side of the spinal column. The 1st and 2nd injections were made as contiguous as possible and the 2nd and 3rd injections in a distance of about 2 cm.
- Frequency of applications: once
- Duration (epicutaneous): One week after intradermal induction topical induction was performed with an exposure duration of 48 hours
- Concentrations: Intradermal induction: 5% and topical induction 12%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1
- Site: test item and control group: left flank (caudal). A patch loaded only with the vehicle was placed also on the left flank (cranial) as control
- Concentrations of test group: 6%
- Evaluation (hr after challenge): 48 and 72 hours after start of the application
- Positive control substance(s):
- not specified
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 6%
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Clinical observations:
- see under "Any other infromation on results"
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 6%
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- see under "Any other infromation on results"
- Remarks on result:
- no indication of skin sensitisation
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 6%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- see under "Any other infromation on results"
- Remarks on result:
- no indication of skin sensitisation
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 6%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- see under "Any other infromation on results"
- Remarks on result:
- no indication of skin sensitisation
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
General Examinations:
Appearance and behaviour of the test item group were not different from the control group.
At the end of the study, the mean body weight of the treatment group animals was in the same range than that of the control group animals.
After the intradermal induction (first induction) the animals in the control group showed after 48 hour:
• red wheal with red surrounding
• encrustation
• white wheal with red surrounding
The animals in the test item group showed after 48 hours:
• red wheal with red surrounding
• encrustation
• white wheal with encrustation
After 7 days the following effects were recorded at the injection sites in the control group and in the test item group: wheals and encrustations.
At day 9, directly after removal of the patch of the second induction, the treatment area of the second induction showed skin effects (grade 1) in 3 of 10 animals in the test item group and no skin effects in the control group.
Challenge with a concentration of 6%:
Animal No. |
Test item patch |
Control patch |
||
Control group |
||||
1 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
0 |
Test item group |
||||
6 |
0 |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
0 |
9 |
0 |
0 |
0 |
0 |
10 |
1 |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
0 |
12 |
0 |
0 |
0 |
0 |
13 |
1 |
1 |
0 |
0 |
14 |
0 |
0 |
0 |
0 |
15 |
0 |
0 |
0 |
0 |
Grading of the Skin Reaction:
The skin reactions were assessed 48 and 72 hours after the start of the application to induce the challenge and for the range-finding studies to establish concentrations for the topical induction and challenge in accordance with the following pattern:
0= No reaction
1 = Slight localized redness
2 = Moderate confluent redness
3 = Severe redness and swelling
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the maximization test and with respect to the evaluation criteria the test item exhibits no skin-sensitization potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.